Literature DB >> 30959208

Extracellular vesicles in autoimmune vasculitis - Little dirts light the fire in blood vessels.

Xiuhua Wu1, Yu Liu2, Wei Wei3, Ming-Lin Liu4.   

Abstract

Systemic vasculitis is diverse group of autoimmune disorders which are characterized by inflammation of blood vessel walls with deep aching and burning pain. Their underlying etiology and pathophysiology still remain poorly understood. Extracellular vesicles (EVs), including exosomes, microvesicles (MVs), and apoptotic bodies, are membrane vesicular structures that are released either during cell activation, or when cells undergo programmed cell death, including apoptosis, necroptosis, and pyroptosis. Although EVs were thought as cell dusts, but now they have been found to be potently active since they harbor bioactive molecules, such as proteins, lipids, nucleic acids, or multi-molecular complexes. EVs can serve as novel mediators for cell-to-cell communications by delivery bioactive molecules from their parental cells to the recipient cells. Earlier studies mainly focused on MVs budding from membrane surface. Recent studies demonstrated that EVs may also carry molecules from cytoplasm or even from nucleus of their parental cells, and these EVs may carry autoantigens and are important in vasculitis. EVs may play important roles in vasculitis through their potential pathogenic involvements in inflammation, autoimmune responses, procoagulation, endothelial dysfunction/damage, angiogenesis, and intimal hyperplasia. EVs have also been used as specific biomarkers for diagnostic use or disease severity monitoring. In this review, we have focused on the aspects of EV biology most relevant to the pathogenesis of vasculitis, discussed their perspective insights, and summarized the exist literature on EV relevant studies in vasculitis, therefore provides an integration of current knowledge regarding the novel role of EVs in systemic vasculitis.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Autoimmunity; Extracellular vesicles; Inflammation; Systemic vasculitis

Mesh:

Year:  2019        PMID: 30959208      PMCID: PMC6956404          DOI: 10.1016/j.autrev.2018.12.007

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  200 in total

Review 1.  New horizons in the analysis of circulating cell-derived microparticles.

Authors:  Lawrence L Horstman; Wenche Jy; Joaquin J Jimenez; Carlos Bidot; Yeon S Ahn
Journal:  Keio J Med       Date:  2004-12

2.  Oxidative stress elicits platelet/leukocyte inflammatory interactions via HMGB1: a candidate for microvessel injury in sytemic sclerosis.

Authors:  Norma Maugeri; Patrizia Rovere-Querini; Mattia Baldini; Elena Baldissera; Maria Grazia Sabbadini; Marco E Bianchi; Angelo A Manfredi
Journal:  Antioxid Redox Signal       Date:  2014-01-17       Impact factor: 8.401

3.  Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles.

Authors:  Ming-Lin Liu; Michael P Reilly; Peter Casasanto; Steven E McKenzie; Kevin Jon Williams
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-12-07       Impact factor: 8.311

4.  Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide.

Authors:  Roberto Lande; Josh Gregorio; Valeria Facchinetti; Bithi Chatterjee; Yi-Hong Wang; Bernhard Homey; Wei Cao; Yui-Hsi Wang; Bing Su; Frank O Nestle; Tomasz Zal; Ira Mellman; Jens-Michael Schröder; Yong-Jun Liu; Michel Gilliet
Journal:  Nature       Date:  2007-09-16       Impact factor: 49.962

5.  Endothelium-derived microparticles impair endothelial function in vitro.

Authors:  Sergey V Brodsky; Fan Zhang; Alberto Nasjletti; Michael S Goligorsky
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-05       Impact factor: 4.733

6.  Phosphatidylserine receptor is required for clearance of apoptotic cells.

Authors:  Ming O Li; Matthew R Sarkisian; Wajahat Z Mehal; Pasko Rakic; Richard A Flavell
Journal:  Science       Date:  2003-11-28       Impact factor: 47.728

7.  Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing.

Authors:  E van der Pol; F A W Coumans; A E Grootemaat; C Gardiner; I L Sargent; P Harrison; A Sturk; T G van Leeuwen; R Nieuwland
Journal:  J Thromb Haemost       Date:  2014-06-19       Impact factor: 5.824

8.  Phosphatidylserine externalization, "necroptotic bodies" release, and phagocytosis during necroptosis.

Authors:  Sefi Zargarian; Inbar Shlomovitz; Ziv Erlich; Aria Hourizadeh; Yifat Ofir-Birin; Ben A Croker; Neta Regev-Rudzki; Liat Edry-Botzer; Motti Gerlic
Journal:  PLoS Biol       Date:  2017-06-26       Impact factor: 8.029

9.  The Usefulness of Platelet-derived Microparticle as Biomarker of Antiplatelet Therapy in Kawasaki Disease.

Authors:  Hyun Jung Kim; Eun Hye Choi; Yeon Jung Lim; Hong Ryang Kil
Journal:  J Korean Med Sci       Date:  2017-07       Impact factor: 2.153

Review 10.  The Ability of Extracellular Vesicles to Induce a Pro-Inflammatory Host Response.

Authors:  Maike E van Hezel; Rienk Nieuwland; Robin van Bruggen; Nicole P Juffermans
Journal:  Int J Mol Sci       Date:  2017-06-16       Impact factor: 5.923

View more
  13 in total

Review 1.  Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.

Authors:  Susmita Sil; Raghubendra Singh Dagur; Ke Liao; Eric S Peeples; Guoku Hu; Palsamy Periyasamy; Shilpa Buch
Journal:  J Neuroimmune Pharmacol       Date:  2019-08-27       Impact factor: 4.147

2.  Profile of circulating extracellular vesicles microRNA correlates with the disease activity in granulomatosis with polyangiitis.

Authors:  Marcin Surmiak; Katarzyna Wawrzycka-Adamczyk; Joanna Kosałka-Węgiel; Stanisław Polański; Marek Sanak
Journal:  Clin Exp Immunol       Date:  2022-05-13       Impact factor: 4.330

3.  Profile of circulating extracellular vesicles microRNA correlates with the disease activity in granulomatosis with polyangiitis.

Authors:  Marcin Surmiak; Katarzyna Wawrzycka-Adamczyk; Joanna Kosałka-Węgiel; Stanisław Polański; Marek Sanak
Journal:  Clin Exp Immunol       Date:  2022-03-03       Impact factor: 5.732

Review 4.  Molecular characteristics and functional differences of anti-PM/Scl autoantibodies and two other distinct and unique supramolecular structures known as "EXOSOMES".

Authors:  Peter J Wermuth; Sergio A Jimenez
Journal:  Autoimmun Rev       Date:  2020-08-12       Impact factor: 9.754

Review 5.  Recent advances in Extracellular Vesicles and their involvements in vasculitis.

Authors:  Nan Yang; Yin Zhao; Xiuhua Wu; Na Zhang; Haoming Song; Wei Wei; Ming-Lin Liu
Journal:  Free Radic Biol Med       Date:  2021-05-02       Impact factor: 8.101

Review 6.  Extracellular vesicles mediate cellular interactions in renal diseases-Novel views of intercellular communications in the kidney.

Authors:  Ping L Zhang; Ming-Lin Liu
Journal:  J Cell Physiol       Date:  2021-01-11       Impact factor: 6.513

Review 7.  Current State of Precision Medicine in Primary Systemic Vasculitides.

Authors:  Erkan Demirkaya; Zehra Serap Arici; Micol Romano; Roberta Audrey Berard; Ivona Aksentijevich
Journal:  Front Immunol       Date:  2019-12-17       Impact factor: 7.561

Review 8.  Extracellular Vesicles Are Key Regulators of Tumor Neovasculature.

Authors:  Naoya Kuriyama; Yusuke Yoshioka; Shinsuke Kikuchi; Nobuyoshi Azuma; Takahiro Ochiya
Journal:  Front Cell Dev Biol       Date:  2020-12-09

Review 9.  Current understanding of the role of Adipose-derived Extracellular Vesicles in Metabolic Homeostasis and Diseases: Communication from the distance between cells/tissues.

Authors:  Chun-Jun Li; Qian-Hua Fang; Ming-Lin Liu; Jing-Na Lin
Journal:  Theranostics       Date:  2020-06-12       Impact factor: 11.556

10.  Thromboangiitis obliterans plasma-derived exosomal miR-223-5p inhibits cell viability and promotes cell apoptosis of human vascular smooth muscle cells by targeting VCAM1.

Authors:  Ying Deng; Jindong Tong; Weijun Shi; Zhongyi Tian; Bo Yu; Jingdong Tang
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.